Highlights
KLSE: PHARMA (7081)       PHARMANIAGA BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
0.705   -0.01 (1.40%)  0.70 - 0.715  3,284,300
Analyze this stock with MQ Trader system

Financials


Market Cap: 923 Million

Market Cap 923 Million
NOSH 1,309 Million

Latest Audited Result:  31-Dec-2020

Latest Audited Result: 31-Dec-2020
Announcement Date 24-May-2021
Next Audited Result: 31-Dec-2021
Est. Ann. Date: 24-May-2022
Est. Ann. Due Date: 29-Jun-2022

Latest Quarter:  30-Sep-2021 [#3]

Latest Quarter: 30-Sep-2021 [#3]
Announcement Date 19-Nov-2021
Next Quarter: 31-Dec-2021
Est. Ann. Date: 17-Mar-2022
Est. Ann. Due Date: 01-Mar-2022
QoQ | YoY   263.65%  |    3,355.96%

Annual (Unaudited) ( EPS: 2.10, P/E: 33.57 )

Revenue | NP to SH 2,725,071  |  27,489
RPS | P/RPS 208.16 Cent  |  0.34
EPS | P/E | EY 2.10 Cent  |  33.57  |  2.98%
DPS | DY | Payout % 2.20 Cent  |  3.12%  |  104.63%
NAPS | P/NAPS 0.26  |  2.74
YoY   118.42%
NP Margin | ROE 0.96%  |  8.15%
F.Y. | Ann. Date 31-Dec-2020  |  17-Mar-2021

T4Q Result ( EPS: 6.14, P/E: 11.49 )

Revenue | NP to SH 4,737,880  |  80,344
RPS | P/RPS 361.91 Cent  |  0.19
EPS | P/E | EY 6.14 Cent  |  11.49  |  8.71%
DPS | DY | Payout % 4.50 Cent  |  6.38%  |  73.30%
NAPS | P/NAPS 0.30  |  2.36
QoQ | YoY   151.46%  |    155.49%
NP Margin | ROE 1.69%  |  20.53%
F.Y. | Ann. Date 30-Sep-2021  |  19-Nov-2021

Annualized Result ( EPS: 8.83, P/E: 7.99 )

Revenue | NP to SH 5,471,062  |  115,566
RPS | P/RPS 417.92 Cent  |  0.17
EPS | P/E | EY 8.83 Cent  |  7.99  |  12.52%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   56.85%  |    156.28%
NP Margin | ROE 2.12%  |  29.52%
F.Y. | Ann. Date 30-Sep-2021  |  19-Nov-2021


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2021 19-Nov-2021 30-Sep-2021 3 4,103,297 151,987 87,040 86,675 56,292 391,428 64.95% 2.12% 22.14% 1,309,126 313.44 313.44 6.62 6.62 4.30 4.30 0.2990 0.30   135.27%   156.28% 30-Sep-2021 0.835 0.27 12.61 2.79 7.93% 5.15% 19-Nov-2021 0.845 0.27 12.76 2.83 7.84% 5.09%
31-Dec-2021 20-Aug-2021 30-Jun-2021 2 1,970,622 53,768 36,716 36,840 30,100 357,275 81.71% 1.86% 10.31% 1,308,702 150.58 150.53 2.82 2.81 2.30 2.30 0.2730 0.27   59.23%   13.78% 30-Jun-2021 5.29 3.51 187.92 19.38 0.53% 0.43% 20-Aug-2021 0.925 0.61 32.86 3.39 3.04% 2.49%
31-Dec-2021 21-May-2021 31-Mar-2021 1 793,499 31,524 22,828 23,136 10,468 355,919 45.25% 2.88% 6.50% 261,705 303.20 60.61 8.84 1.77 4.00 0.80 1.3600 0.27   -15.84%   3.29% 31-Mar-2021 3.26 1.08 36.88 2.40 2.71% 1.23% 21-May-2021 4.03 1.33 45.59 2.96 2.19% 0.99%
31-Dec-2020 17-Mar-2021 31-Dec-2020 4 2,725,071 35,793 26,269 27,489 28,761 337,298 104.63% 0.96% 8.15% 261,472 1,042.20 208.16 10.51 2.10 11.00 2.20 1.2900 0.26   -18.72%   118.42% 31-Dec-2020 5.00 0.48 47.56 3.88 2.10% 2.20% 3.49 0.33 33.20 2.71 3.01% 3.15%
31-Dec-2020 19-Nov-2020 30-Sep-2020 3 2,090,488 49,299 33,316 33,820 26,139 345,040 77.29% 1.59% 9.80% 261,394 799.75 159.69 12.94 2.58 10.00 2.00 1.3200 0.26   4.45%   15.12% 30-Sep-2020 4.32 0.54 33.39 3.27 2.99% 2.31% 19-Nov-2020 5.72 0.72 44.21 4.33 2.26% 1.75%
31-Dec-2020 19-Aug-2020 30-Jun-2020 2 1,465,684 45,206 32,022 32,378 22,204 357,891 68.58% 2.18% 9.05% 261,235 561.06 111.96 12.39 2.47 8.50 1.70 1.3700 0.27   44.55%   12.04% 30-Jun-2020 2.22 0.40 17.91 1.62 5.58% 3.83% 19-Aug-2020 4.42 0.79 35.66 3.23 2.80% 1.92%
31-Dec-2020 19-May-2020 31-Mar-2020 1 819,921 30,880 22,415 22,399 15,673 350,047 69.98% 2.73% 6.40% 261,229 313.87 62.63 8.57 1.71 6.00 1.20 1.3400 0.27   115.01%   14.18% 31-Mar-2020 1.26 0.40 14.69 0.94 6.81% 4.76% 19-May-2020 1.88 0.60 21.93 1.40 4.56% 3.19%
31-Dec-2019 20-Feb-2020 31-Dec-2019 4 2,820,530 -191,865 -149,447 -149,219 22,177 336,573 - % -5.30% -44.33% 260,910 1,081.04 215.45 -57.19 -11.40 8.50 1.69 1.2900 0.26   -607.91%   -451.37% 31-Dec-2019 2.06 0.19 -3.60 1.60 -27.76% 4.13% 20-Feb-2020 2.04 0.19 -3.57 1.58 -28.04% 4.17%
31-Dec-2019 20-Nov-2019 30-Sep-2019 3 2,104,847 46,609 29,286 29,379 22,168 516,387 75.46% 1.39% 5.69% 260,802 807.07 160.78 11.26 2.24 8.50 1.69 1.9800 0.39   1.66%   -22.75% 30-Sep-2019 2.44 0.30 21.66 1.23 4.62% 3.48% 20-Nov-2019 2.21 0.27 19.62 1.12 5.10% 3.85%
31-Dec-2019 23-Aug-2019 30-Jun-2019 2 1,387,998 42,724 28,910 28,898 22,149 518,564 76.65% 2.08% 5.57% 260,585 532.65 106.02 11.09 2.21 8.50 1.69 1.9900 0.40   47.31%   25.75% 28-Jun-2019 2.84 0.53 25.61 1.43 3.90% 2.99% 23-Aug-2019 2.66 0.50 23.99 1.34 4.17% 3.20%
31-Dec-2019 16-May-2019 31-Mar-2019 1 786,108 30,243 19,648 19,617 15,630 528,825 79.68% 2.50% 3.71% 260,505 301.76 60.05 7.53 1.50 6.00 1.19 2.0300 0.40   -53.81%   11.55% 29-Mar-2019 2.27 0.75 30.14 1.12 3.32% 2.64% 16-May-2019 2.36 0.78 31.34 1.16 3.19% 2.54%
31-Dec-2018 21-Feb-2019 31-Dec-2018 4 2,384,956 70,220 43,230 42,468 41,621 509,862 98.01% 1.81% 8.33% 260,134 916.82 182.18 16.33 3.24 16.00 3.18 1.9600 0.39   11.67%   -21.10% 31-Dec-2018 2.78 0.30 17.03 1.42 5.87% 5.76% 21-Feb-2019 2.76 0.30 16.91 1.41 5.92% 5.80%
31-Dec-2018 19-Nov-2018 30-Sep-2018 3 1,788,312 58,280 38,660 38,031 36,401 522,618 95.71% 2.16% 7.28% 260,009 687.79 136.60 14.63 2.91 14.00 2.78 2.0100 0.40   65.50%   18.76% 28-Sep-2018 2.89 0.42 19.76 1.44 5.06% 4.84% 19-Nov-2018 3.09 0.45 21.13 1.54 4.73% 4.53%
31-Dec-2018 17-Aug-2018 30-Jun-2018 2 1,200,652 40,677 23,355 22,980 23,383 519,642 101.76% 1.95% 4.42% 259,821 462.11 91.71 8.84 1.76 9.00 1.79 2.0000 0.40   30.67%   -19.21% 29-Jun-2018 2.88 0.62 32.56 1.44 3.07% 3.13% 17-Aug-2018 3.11 0.67 35.16 1.56 2.84% 2.89%
31-Dec-2018 16-May-2018 31-Mar-2018 1 617,923 28,707 17,589 17,586 12,991 524,838 73.87% 2.85% 3.35% 259,821 237.83 47.20 6.77 1.34 5.00 0.99 2.0200 0.40   -67.33%   -7.07% 30-Mar-2018 4.28 1.80 63.23 2.12 1.58% 1.17% 16-May-2018 4.07 1.71 60.13 2.01 1.66% 1.23%
31-Dec-2017 27-Feb-2018 31-Dec-2017 4 2,323,960 73,064 55,087 53,823 49,314 526,888 91.62% 2.37% 10.22% 259,551 895.38 177.52 20.74 4.11 19.00 3.77 2.0300 0.40   68.08%   18.04% 29-Dec-2017 4.60 0.51 22.18 2.27 4.51% 4.13% 27-Feb-2018 4.04 0.45 19.48 1.99 5.13% 4.70%
31-Dec-2017 15-Nov-2017 30-Sep-2017 3 1,710,764 53,198 32,899 32,023 33,729 531,892 105.33% 1.92% 6.02% 259,460 659.36 130.68 12.34 2.45 13.00 2.58 2.0500 0.41   12.59%   -31.04% 29-Sep-2017 4.14 0.63 33.54 2.02 2.98% 3.14% 15-Nov-2017 3.82 0.58 30.95 1.86 3.23% 3.40%
31-Dec-2017 16-Aug-2017 30-Jun-2017 2 1,136,261 37,927 29,009 28,443 20,742 541,894 72.93% 2.55% 5.25% 259,279 438.24 86.80 10.97 2.17 8.00 1.58 2.0900 0.41   50.31%   -14.77% 30-Jun-2017 4.58 1.05 41.75 2.19 2.40% 1.75% 16-Aug-2017 4.19 0.96 38.20 2.00 2.62% 1.91%
31-Dec-2017 16-May-2017 31-Mar-2017 1 618,294 27,777 19,258 18,923 10,368 544,360 54.79% 3.11% 3.48% 259,219 238.52 47.23 7.30 1.45 4.00 0.79 2.1000 0.42   -58.50%   2.96% 31-Mar-2017 4.89 2.05 66.99 2.33 1.49% 0.82% 16-May-2017 4.72 1.98 64.66 2.25 1.55% 0.85%
31-Dec-2016 21-Feb-2017 31-Dec-2016 4 2,189,022 72,017 45,859 45,599 41,457 531,169 90.92% 2.09% 8.58% 259,107 844.83 167.21 17.60 3.48 16.00 3.17 2.0500 0.41   -1.80%   -45.74% 30-Dec-2016 5.30 0.63 30.12 2.59 3.32% 3.02% 21-Feb-2017 5.12 0.61 29.09 2.50 3.44% 3.13%
31-Dec-2016 21-Nov-2016 30-Sep-2016 3 1,606,206 67,948 46,759 46,435 33,667 530,907 72.50% 2.91% 8.75% 258,979 620.21 122.69 17.93 3.55 13.00 2.57 2.0500 0.41   39.14%   -31.70% 30-Sep-2016 5.58 0.90 31.12 2.72 3.21% 2.33% 21-Nov-2016 5.70 0.92 31.79 2.78 3.15% 2.28%
31-Dec-2016 19-Aug-2016 30-Jun-2016 2 1,090,991 48,025 34,111 33,374 23,302 524,041 69.82% 3.13% 6.37% 258,913 421.37 83.34 12.89 2.55 9.00 1.78 2.0240 0.40   81.59%   -30.49% 30-Jun-2016 5.50 1.31 42.67 2.72 2.34% 1.64% 19-Aug-2016 5.62 1.33 43.60 2.78 2.29% 1.60%
31-Dec-2016 13-May-2016 31-Mar-2016 1 559,195 26,538 18,470 18,379 10,354 515,906 56.34% 3.30% 3.56% 258,859 216.02 42.72 7.10 1.40 4.00 0.79 1.9930 0.39   -78.13%   -42.19% 31-Mar-2016 5.76 2.67 81.13 2.89 1.23% 0.69% 13-May-2016 5.60 2.59 78.87 2.81 1.27% 0.71%
31-Dec-2015 15-Feb-2016 31-Dec-2015 4 2,189,312 112,722 84,584 84,044 77,674 529,482 92.42% 3.86% 15.87% 258,915 845.57 167.23 32.46 6.42 30.00 5.93 2.0450 0.40   23.63%   -10.44% 31-Dec-2015 6.36 0.75 19.59 3.11 5.10% 4.72% 15-Feb-2016 6.19 0.73 19.07 3.03 5.24% 4.85%
31-Dec-2015 26-Nov-2015 30-Sep-2015 3 1,509,162 89,005 68,543 67,982 59,542 534,070 87.59% 4.54% 12.73% 258,880 582.96 115.28 26.26 5.19 23.00 4.55 2.0630 0.41   41.60%   18.96% 30-Sep-2015 6.50 1.12 24.75 3.15 4.04% 3.54% 26-Nov-2015 6.50 1.12 24.75 3.15 4.04% 3.54%
31-Dec-2015 17-Aug-2015 30-Jun-2015 2 984,749 63,668 48,568 48,011 36,234 527,991 75.47% 4.93% 9.09% 258,819 380.48 75.22 18.55 3.67 14.00 2.77 2.0400 0.40   51.01%   13.79% 30-Jun-2015 7.13 1.87 38.44 3.50 2.60% 1.96% 17-Aug-2015 5.65 1.48 30.46 2.77 3.28% 2.48%
31-Dec-2015 18-May-2015 31-Mar-2015 1 471,904 38,612 31,926 31,794 18,123 528,173 57.00% 6.77% 6.02% 258,908 182.27 36.05 12.28 2.43 7.00 1.38 2.0400 0.40   -66.12%   21.27% 31-Mar-2015 6.00 3.29 48.86 2.94 2.05% 1.17% 18-May-2015 6.91 3.79 56.27 3.39 1.78% 1.01%
31-Dec-2014 23-Feb-2015 31-Dec-2014 4 2,122,933 125,580 94,225 93,844 72,486 525,526 77.24% 4.44% 17.86% 258,880 820.05 162.16 36.25 7.17 28.00 5.54 2.0300 0.40   64.22%   70.01% 31-Dec-2014 4.58 0.56 12.63 2.26 7.91% 6.11% 23-Feb-2015 5.28 0.64 14.57 2.60 6.87% 5.30%
31-Dec-2014 21-Nov-2014 30-Sep-2014 3 1,495,830 87,726 57,604 57,147 41,429 507,513 72.50% 3.85% 11.26% 258,935 577.69 114.26 22.07 4.37 16.00 3.16 1.9600 0.39   35.45%   66.19% 30-Sep-2014 4.63 0.80 20.98 2.36 4.77% 3.46% 21-Nov-2014 4.45 0.77 20.16 2.27 4.96% 3.60%
31-Dec-2014 21-Aug-2014 30-Jun-2014 2 993,744 62,781 42,603 42,192 20,707 502,162 49.08% 4.29% 8.40% 258,846 383.91 75.91 16.30 3.22 8.00 1.58 1.9400 0.38   60.93%   37.72% 30-Jun-2014 4.61 1.20 28.28 2.38 3.54% 1.74% 21-Aug-2014 4.62 1.20 28.34 2.38 3.53% 1.73%
31-Dec-2014 14-May-2014 31-Mar-2014 1 468,672 38,159 26,646 26,217 10,352 515,022 39.49% 5.69% 5.09% 258,805 181.09 35.80 10.13 2.00 4.00 0.79 1.9900 0.39   -52.51%   5.84% 31-Mar-2014 4.46 2.46 44.03 2.24 2.27% 0.90% 14-May-2014 4.70 2.60 46.40 2.36 2.16% 0.85%
31-Dec-2013 24-Feb-2014 31-Dec-2013 4 1,946,639 92,997 56,761 55,200 41,477 486,754 75.14% 2.92% 11.34% 258,911 751.85 148.70 21.32 4.22 16.02 3.17 1.8800 0.37   60.53%   -10.55% 31-Dec-2013 4.45 0.59 20.87 2.37 4.79% 3.60% 24-Feb-2014 4.29 0.57 20.12 2.28 4.97% 3.73%
31-Dec-2013 19-Nov-2013 30-Sep-2013 3 1,378,779 59,990 35,494 34,387 25,427 473,857 73.95% 2.57% 7.26% 258,938 532.47 105.32 13.28 2.63 9.82 1.94 1.8300 0.36   12.24%   -50.63% 30-Sep-2013 4.82 0.91 36.30 2.63 2.76% 2.04% 19-Nov-2013 4.72 0.89 35.54 2.58 2.81% 2.08%
31-Dec-2013 16-Aug-2013 30-Jun-2013 2 937,972 46,529 31,324 30,636 17,661 481,681 57.65% 3.34% 6.36% 258,968 362.20 71.65 11.83 2.34 6.82 1.35 1.8600 0.37   23.68%   -31.00% 28-Jun-2013 4.49 1.24 37.95 2.41 2.63% 1.52% 16-Aug-2013 4.66 1.29 39.39 2.51 2.54% 1.46%
31-Dec-2013 15-May-2013 31-Mar-2013 1 500,339 36,924 25,153 24,771 8,825 484,829 35.63% 5.03% 5.11% 117,676 425.18 38.22 21.05 1.89 7.50 0.67 4.1200 0.37   -59.86%   -13.64% 29-Mar-2013 8.26 1.94 39.24 2.00 2.55% 0.91% 15-May-2013 9.26 2.18 43.99 2.25 2.27% 0.81%
31-Dec-2012 18-Feb-2013 31-Dec-2012 4 1,812,346 103,313 63,205 61,710 41,187 471,886 66.74% 3.49% 13.08% 117,677 1,540.10 138.44 52.44 4.71 35.00 3.15 4.0100 0.36   -11.39%   18.32% 31-Dec-2012 8.10 0.53 15.45 2.02 6.47% 4.32% 18-Feb-2013 7.80 0.51 14.87 1.95 6.72% 4.49%
31-Dec-2012 06-Nov-2012 30-Sep-2012 3 1,329,942 99,066 70,674 69,645 29,420 496,623 42.24% 5.31% 14.02% 117,683 1,130.10 101.59 59.18 5.32 25.00 2.25 4.2200 0.38   56.87%   73.18% 28-Sep-2012 7.55 0.67 12.76 1.79 7.84% 3.31% 06-Nov-2012 8.25 0.73 13.94 1.95 7.17% 3.03%
31-Dec-2012 08-Aug-2012 30-Jun-2012 2 903,482 70,573 45,138 44,398 17,650 481,282 39.76% 5.00% 9.22% 117,672 767.79 69.01 37.73 3.39 15.00 1.35 4.0900 0.37   54.78%   50.99% 29-Jun-2012 10.18 1.33 26.98 2.49 3.71% 1.47% 08-Aug-2012 8.83 1.15 23.40 2.16 4.27% 1.70%
31-Dec-2012 03-May-2012 31-Mar-2012 1 446,745 42,955 29,061 28,685 8,824 474,161 30.76% 6.51% 6.05% 117,657 379.70 34.13 24.38 2.19 7.50 0.67 4.0300 0.36   -45.00%   85.26% 30-Mar-2012 5.90 1.55 24.20 1.46 4.13% 1.27% 03-May-2012 5.90 1.55 24.20 1.46 4.13% 1.27%
31-Dec-2011 22-Feb-2012 31-Dec-2011 4 1,520,981 73,186 52,785 52,157 35,304 514,273 67.69% 3.47% 10.14% 117,682 1,292.44 116.18 44.32 3.98 30.00 2.70 4.3700 0.39   29.70%   71.66% 30-Dec-2011 5.36 0.41 12.09 1.23 8.27% 5.60% 22-Feb-2012 5.90 0.46 13.31 1.35 7.51% 5.08%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Trade this stock for as low as 0.05% brokerage. Find out more.
  5 people like this.
 
Cipta wow! The new Bstead Chairman very powerful! Just One week appointment already win 10 years contract for its subsidiary. Who say flying car can not fly? ^_^ Wish Pharma fly high like Flying Car in year 2022!!!. Wish those bler & ei can win a lot money and need not holiday in KLSEi3 forum at year end but can have proper vocation in Dubai this year! Bravo New Year! Roar!!!!
12/01/2022 9:43 AM
chowwei Wa Lao Er
Sell On News
12/01/2022 11:40 AM
chowwei 哎哟 不错噢 救星到
HLIB 把它救了上来
12/01/2022 12:33 PM
Cyber_moneyman Huat ah.. kasi goreng Pharma kaw²
12/01/2022 6:34 PM
Cyber_moneyman Kasi CNY Ang Pow
12/01/2022 6:34 PM
chowwei 机会是留给 有信心的人
13/01/2022 9:30 AM
VTrade Ppv say sinox3 will take the 4th
14/01/2022 10:59 AM
chowwei 上个星期 星期一
都是 Sell On News
17/01/2022 11:03 AM
chowwei 看来看去 又朝向 0.695
HLIB 不给大力 顶着它
19/01/2022 9:40 AM
chowwei 最近 股市 大红
每天 跟你跌 10点
问你 怕了没
马股 很难 找到吃
19/01/2022 10:03 AM
chowwei 股市 很无情
完全不给 散户
一条生路 过年
19/01/2022 5:36 PM
kfliau 步步惊心!
19/01/2022 5:37 PM
CT Lew Current market needs to trade carefully.
19/01/2022 5:38 PM
kfliau @chowwei 你现在还要谢谢pharma老板吗?
20/01/2022 7:59 AM
Trevor777 Yes, Mr Liau, these people would never listen or see Facts and Figures even when history tells the truth.

Anyway, they are only small kids playing shares for the 1st time, buying only 200 to 300 units for fun. But they sure talk damn big!

They only lose peanuts or gets locked at same price for years.
20/01/2022 8:58 AM
Cipta From recent development, do you still confident on Malaysia SC?

If you are not confident to market regulator on Insider Trading, fake account, misleading info & justly, will you believe Bursa, GLC will hold higher moral ground than SC?

Last week so optimism, shout confident, must trust, good will, reward on good fate; this week moan, shout run, pain, beg to the Croc to give a life line. So cheap a soul who emotion totally controlled by others. Wake up! Think independently!
20/01/2022 10:16 AM
chowwei 耐心成金 时间是 最好良药
20/01/2022 2:56 PM
Trevor777 不见棺材,不流泪
20/01/2022 3:16 PM
Trevor777 Just realised I'm responding to a kid who only bought 200-300 units for fun from his year end bonus! Waste of time.

Let him be locked here at 70c for years.
20/01/2022 3:25 PM
chowwei 慢慢进场 1年 进4次
目标 400,000 Units
目前 216,000 Units
20/01/2022 9:04 PM
chowwei 要写几 Units 人家才会 看懂
如果写 / 几张 / 几粒 / 看不懂
20/01/2022 9:07 PM
chowwei 买 200-300 Units
比如股价是 0.730
200 Units = RM146
300 Units = RM219
只是给水钱都亏死你
21/01/2022 1:36 AM
chowwei 放着它 5年 到 10年
等 再次重来 以前辉煌
21/01/2022 2:08 PM
kfliau 等到花儿也谢了
21/01/2022 7:47 PM
Trevor777 如果相信你拥有216,000 units,母猪可以爬树。
22/01/2022 8:59 AM
chowwei 216,000 Units 大概是 RM170,000
现在 马来西亚 东西那么贵 不算有钱人
22/01/2022 12:34 PM
chowwei 发马 216,000 Units 大概是 RM170,000 左右
现在 马来西亚 东西 变那么贵 不算是有钱人
22/01/2022 12:36 PM
Trevor777 有钱人也不用等年终红利买股!

有人说屁话.
22/01/2022 1:29 PM
Trevor777 USA, deaths due to Covid : more than 850,000 lives

China, deaths due to Covid : more than 4,000

Who is lying?
22/01/2022 1:31 PM
miqie21 China’s zero tolerance policy is very effective.
22/01/2022 7:23 PM
周 海 China is using 'zero tolerance policy' to show its advantage against democratic policies. I thought China has given up the 'zero tolerance policy' a few days ago? By renaming it to something like economic....
22/01/2022 7:33 PM
Legend Pfizer Inc chief executive Albert Bourla said on Saturday that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.

Pfizer-BioNtech’s Covid-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant but less effective in preventing transmission.

With cases soaring, some countries have expanded Covid-19 vaccine booster programmes or shortened the gap between shots as governments scramble to shore up protection.

In an interview with Israel’s N12 News, Bourla was asked whether he sees booster shots being administered every four to five months on a regular basis.

“This will not be a good scenario. What I’m hoping (is) that we will have a vaccine that you will have to do once a year,” Bourla said.

“Once a year – it is easier to convince people to do it. It is easier for people to remember.

“So from a public health perspective, it is an ideal situation. We are looking to see if we can create a vaccine that covers Omicron and doesn’t forget the other variants and that could be a solution,” Bourla said.

Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March.

Citing three studies, the US Centers for Disease Control and Prevention said on Friday that a third dose of an mRNA vaccine is key to fighting Omicron, providing 90% protection against hospitalisation.

A preliminary study published by Israel’s Sheba Medical Center on Monday found that a fourth shot increases antibodies to even higher levels than the third but was likely not enough to fend off Omicron. Nonetheless, a second booster was still advised for risk groups, Sheba said.
23/01/2022 9:26 AM
Cipta Zero Risk Management or Risk Management?

Which is suitable to Malaysia?

Is taking vaccine is a Zero Risk?
If NOT, why take risk to jap since the country is operating in Zero Risk Management.
If YES, And it is effective, and it covers 95% of your population, then the risk should be very low close to normal sickness like flu. Nothing to scare of.

Instead of milking the pharmaceutical companies in huge profit, why not finding the nature HOST ? China has every advantage to find the natural host. With China Speed, sure can find its natural antibody.

**Reminder: A Malaysian Doctor had found the Nipah natural host in only one month 24 years ago.
24/01/2022 8:53 AM
chowwei 如果 现在有人
愿意买 119.1 张
股价就会 冲破 0.740
24/01/2022 10:51 AM
Trevor777 傻子, 你慢慢等....
24/01/2022 1:22 PM
chowwei https://youtu.be/3Y_e8O4ZLgg
RM4200 股息 除于 RM20 等于 210 张股票
https://youtu.be/3Y_e8O4ZLgg
24/01/2022 3:12 PM
chowwei Trevor777
拍 Video 然后 Copy Link 在这里
让我看看 猪怎样爬上树
我吃到那么大 真的没看过 猪爬上树
24/01/2022 3:15 PM
chowwei Trevor777
拍个 Video 然后 Copy Link 到这里
让我开眼界看看 猪到底是怎样爬上树 因为
我吃到那么大 只是听过传说中而已
还没有真正 看过 猪爬上树
24/01/2022 3:19 PM
Trevor777 所以你是, "眼大不见山"
24/01/2022 3:55 PM
chowwei 我不在意 什么 不见猪 不见山 不见海
我只在意 公司要赚大钱 和 公司不会倒闭
24/01/2022 4:52 PM
Cipta https://www.malaysiakini.com/news/608559
27/01/2022 8:51 AM
Cipta Placebo = non protection. Which vaccine you guess most likely if it is true?
27/01/2022 8:53 AM
Cipta https://www.freemalaysiatoday.com/category/nation/2022/01/27/pharmaniaga-chairman-shazalli-redesignated-as-non-independent-director/
27/01/2022 4:08 PM
Cipta UMNO division head is the new Pharma chairman. Go go withdraw your EPF to buy Pharma share. It "will" up to RM2. HOLD it until your cucu give birth your cicit.

This is a Good company. Good products. Good Management. The most important question is: Is it GOOD to you?

Let's see who is the Tiger who is the Goat. Roar~~~~~~
27/01/2022 4:34 PM
kfliau All these political appointees are fleecing the company dry, like felda
27/01/2022 10:59 PM
Karma4444 Umno will help pharmaniaga
28/01/2022 11:38 AM
kfliau Ya, will help it become PN17, lol
28/01/2022 11:47 AM
Trevor777 That Lan-head talked so much, now ran off with tail between legs...hahaha

Die already or not? 70c only.
28/01/2022 12:17 PM
Cipta Since the announcement, from the share price can see Market gives vote of no-confidence.
28/01/2022 8:03 PM
JJPTR RENONG was UMNO COUNTER
SUMATEC UMNO COUNTERS
MRCB UMNO COUNTERS
ALL BECOME NO MO COUNTERS
28/01/2022 8:10 PM